Fig. 3.
Inhibition of ENS by TTX reduces cAMP-stimulated Isc in the colon. A: representative recording of Isc responses to forskolin (FSK) and bumetanide (Bumet) in a rat distal colon segment. Following additions of 500 nM forskolin to mucosal and serosal solutions, 100 μM of bumetanide was added to serosal solution to inhibit the Na+/K+/2Cl− cotransporter, as indicated. B: quantitation of forskolin-stimulated Isc responses in proximal and distal colons. C: representative tracing of Isc responses in a rat distal colon segment to TTX under forskolin-stimulated condition. Following additions of 500 nM forskolin to mucosal and serosal solutions, 2 μM TTX was added to serosal solution, as indicated. D: quantitation of Isc responses to TTX under forskolin-stimulated condition in the proximal and distal colons.